Senior insider sale
CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$122.0K
3K shares
What this filing means
OKEY STEPHANIE plans to sell 3K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $122.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001950047-26-002102
Director
Since Jul 2019
3K
Shares to sell
$122.0K
Approx. market value
3K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/7/2024
3KTotal acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/7/2024 | Restricted Stock Units N/A | 3K | — |
| Total | 3K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3K
Market value
$122.0K
3/3/2026
Total
Units
3K
Value
$122.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/3/2026 | 3K | $122.0K | NASDAQ | Planned |
| Total | 3K | $122.0K | ||